fabrication of square pyramidal microwells for tumor spheroid fabrication

Fabricación seguida de encapsulación 3D de esferoides tumorales en hidrogeles PEG

Tumor spheroids have emerged as useful in vitro tools in studying cancer etiology, pathology, and drug responsiveness1. Traditionally, spheroids have been cultured in conditions such as low adhesion plates or bioreactors, where cell-cell adhesion is favored over cell-surface adhesion2. However, it is now recognized that to recapitulate the tumor microenvironment more faithfully, in vitro spheroid models should capture both cell-cell and cell-matrix interactions. This has prompted multiple groups to design scaffolds, such as hydrogels, where spheroids can be encapsulated3,4. Such hydrogel-based spheroid models enable the elucidation of cell-cell and cell-matrix interactions on various cell behaviors, such as viability, proliferation, stemness, or therapy responsiveness3.
Here, we describe a protocol for the encapsulation of glioblastoma spheroids in polyethylene glycol (PEG) hydrogels. There are multiple literature reports of glioblastoma cell spheroid encapsulation in hydrogels. For example, spheroids were formed by encapsulating U87 cells in PEG hydrogels decorated with an RGDS adhesive ligand and crosslinked with an enzymatically cleavable peptide to determine the effect of hydrogel stiffness on cell behavior5. U87 cells have also been formed in other PEG-based or hyaluronic acid-based hydrogels to expand the cancer stem cell population6 or to explore matrix-mediated mechanisms of chemotherapy resistance7,8,9. Glioblastoma spheroids have also been encapsulated in gelatin hydrogels to study the crosstalk between microglia and cancer cells and its effect on cell invasion10. Overall, such studies have demonstrated the utility of hydrogel-based in vitro models in understanding glioblastoma pathology and devising treatments.
Further, there are different methods for tumor spheroid fabrication and hydrogel encapsulation11. For example, dispersed cells could be seeded in hydrogels and allowed to form spheroids over time5,12. One drawback of such a method is the polydispersity of the formed spheroids, which could lead to differential cell responses. To produce uniform spheroids, cells could be encapsulated in microgels and cultured for extended periods until they invade and remodel the gel13, or cells could be deposited in templated gels with spherical &#39;holes&#39; and allowed to aggregate14. The drawback of these methods is their relative complexity, the need for a droplet generator or other means to form microgels or the &#39;holes&#39; in the gel, and the time it takes for spheroids to grow and mature. Alternatively, spheroids could be pre-formed in microwells9,15,16 or in hanging-drop plates17,18 and then encapsulated in a hydrogel, similar to the technique described here. These methods are simpler and can be done in a higher throughput fashion. Interestingly, it has been shown that the method of spheroid formation can affect spheroid cell behaviors, such as gene expression, cell proliferation, or drug responsiveness19,20.
Here, we focus on glioblastoma since it is a solid tumor whose native environment is the soft, nanoporous brain matrix21, which can be mimicked by a soft, nanoporous hydrogel. Glioblastoma is also the deadliest brain cancer for which there is no available cure22. However, the protocol described here can be used for the encapsulation of spheroids representing any solid tumor. We chose to use PEG hydrogels that are formed through a Michael-type addition reaction23. PEG is a synthetic, non-degradable, and biocompatible hydrogel that is inert and serves as scaffolding and physical cell support but does not support cell attachment23. Cell adhesiveness can be added separately via tethering of whole proteins or adhesive ligands24, and degradability can be added via chemical modifications of the PEG polymer chain or hydrolytically or enzymatically degradable crosslinkers25,26. This allows for biochemical properties to be tuned independently of mechanical or physical hydrogel properties, which could be advantageous in studying cell-matrix interactions. The Michael-type gelation chemistry is selective and happens at physiological conditions; hence, it allows for spheroid encapsulation by simply mixing the spheroids with the hydrogel precursor solution.
Overall, the methodology presented here has several notable characteristics. First, fabricating tumor spheroids in a multiwell assembly is efficient, quick, and the cost of the required materials is low. Second, the spheroids are produced in large batches in a variety of sizes with low polydispersity. Finally, only commercially available materials are required. The utility of the methodology is illustrated by exploring the effect of substrate properties on spheroid cell viability, circularity, and cell stemness.

Autor destacado: Modelo de hidrogel in vitro para estudio de microambiente de glioblastoma

Fabricación y encapsulación de esferoides tumorales en hidrogeles de polietilenglicol para el estudio de las interacciones esferoide-matriz

Fabricación de micropocillos piramidales cuadrados para la fabricación de esferoides tumorales

Para comenzar, vierta dos gramos, o aproximadamente un mililitro, de solución precursora negativa de PDMS en un pocillo de un molde maestro parametálico cuadrado de seis pocillos. Después de cubrir el molde maestro con PDMS, coloque la placa en una desecadora al vacío para desgasificar la solución. A continuación, coloque la placa en un horno a 60 grados centígrados durante 24 horas para curar el PDMS.Una vez que el PDMS se cure pero aún esté caliente, use una espátula para quitar con cuidado el molde de PDMS del molde maestro. Luego, con un punzón de biopsia, córtelo en una losa de 35 milímetros de diámetro. Coloque el molde de PDMS correctamente cortado en una placa de Petri y cúbralo con la tapa para continuar curándolo a temperatura ambiente durante 24 horas más.Para preparar el molde PDMS positivo, coloque una losa de 35 milímetros del molde PDMS negativo en una placa de Petri de 35 milímetros con los micropocillos texturizados hacia arriba. Vierta 2,5 gramos o aproximadamente 1,2 mililitros de solución precursora positiva de PDMS en el molde negativo en la placa de Petri. Desgasifique la solución precursora durante 30 minutos antes de colocarla en el horno a 60 grados centígrados durante tres o cuatro horas.Después del curado, retire los moldes de la placa de Petri. Retire inmediatamente el molde positivo del molde negativo. Use un punzón de biopsia de 10 milímetros para cortar los moldes positivos en losas.A continuación, use unas pinzas para sumergir suavemente el lado plano de cada molde positivo de 10 milímetros en la solución precursora de pegamento PDMS preparada previamente. Coloque con cuidado un molde por pocillo en un pocillo de una placa de 48 pocillos. Presione suavemente cada molde para pegarlo al fondo del pozo.Incuba la placa ensamblada a 60 grados centígrados durante cuatro a 24 horas para curar el pegamento.

fabrication-square-pyramidal-microwells-for-tumor-spheroid

Research

JoVE Journal

Bioengineering

Fabrication of Square Pyramidal Microwells for Tumor Spheroid Fabrication

77 vistas. Para comenzar, vierta dos gramos, o aproximadamente un mililitro, de solución precursora negativa de PDMS en un pocillo de un molde maestro parametálico cuadrado de seis pocillos. Después de cubrir el molde maestro con PDMS, coloque la placa en una desecadora al vacío para desgasificar la solución. A continuación, coloque la placa en un horno a 60 grados centígrados durante 24 horas para curar el PDMS.Una vez que el PDMS se cure pero aún esté caliente, use una espátula para q...

Video: Fabricación de micropocillos piramidales cuadrados para la fabricación de esferoides tumorales

Tumor Spheroid Fabrication and Encapsulation in Polyethylene Glycol Hydrogels for Studying Spheroid-Matrix Interactions

Three-dimensional (3D) encapsulation of spheroids is crucial to adequately replicate the tumor microenvironment for optimal cell growth. Here, we designed an in vitro 3D glioblastoma model for spheroid encapsulation to mimic the tumor extracellular microenvironment. First, we formed square pyramidal microwell molds using polydimethylsiloxane. These microwell molds were then used to fabricate tumor spheroids with tightly controlled sizes from 50-500 &#956;m. Once spheroids were formed, they were harvested and encapsulated in polyethylene glycol (PEG)-based hydrogels. PEG hydrogels are a versatile platform for spheroid encapsulation, as hydrogel properties such as stiffness, degradability, and cell adhesiveness can be tuned independently. Here, we used a representative soft (~8 kPa) hydrogel to encapsulate glioblastoma spheroids. Finally, a method to stain and image spheroids was developed to obtain high-quality images via confocal microscopy. Due to the dense spheroid core and relatively sparse periphery, imaging can be difficult, but using a clearing solution and confocal optical sectioning helps alleviate these imaging difficulties. In summary, we show a method to fabricate uniform spheroids, encapsulate them in PEG hydrogels and perform confocal microscopy on the encapsulated spheroids to study spheroid growth and various cell-matrix interactions.

Here, we present a protocol that enables fast, robust, and cheap fabrication of tumor spheroids followed by hydrogel encapsulation. It is widely applicable as it does not require specialized equipment. It would be particularly useful for exploring spheroid-matrix interactions and building in vitro tissue physiology or pathology models.